Abstract:The final, formatted version of the article will be published soon. You have multiple emails registered with Frontiers: Please enter your email address: If you already have an account, please login You don't have a Frontiers account ? You can register here Objectives: To investigate the effect of gut microbiota from postmenopausal osteoporosis patients on bone mass in mice.Methods: Fecal samples were collected from postmenopausal women with normal bone mass (Con, n=5) and postmenopausal women with osteoporosis (Op, n=5).Microbial composition was identified by shallow shotgun sequencing. Then fecal samples were transplanted into pseudo-sterile mice previously treated with antibiotics for 4 weeks. These mice were categorized into two groups: the Vehicle group (n=7) received fecal samples from individuals with normal bone mass, and the FMT group (n=7) received fecal samples from individuals with osteoporosis. After 8 weeks, bone mass, intestinal microbial composition, intestinal permeability and inflammation were assessed, followed by a correlation analysis.Results: The bone mass was significantly reduced in the FMT group. Microbiota sequencing showed that Shannon index (p < 0.05) and Simpson index (p < 0.05) were significantly increased in Op groups, and β diversity showed significant differences. the recipient mice were similar. linear discriminant analysis effect size (LEfSe) analysis of mice showed that Halobiforma, Enterorhabdus, Alistipes, and Butyricimonas were significantly enriched in the FMT group. Lachnospiraceae and Oscillibacter were significantly enriched in the Vehicle group. H&E staining of intestinal tissues showed obvious intestinal mucosal injury in mice. Intestinal immunohistochemistry showed that the expression of Claudin and ZO-1 in the intestinal tissue of the FMT group mice was decreased. The FITC-Dextran (FD-4) absorption rate and serum soluble CD14 (sCD14) content were increased in FMT mice. Correlation analysis showed that these dominant genera were significantly associated with bone metabolism and intestinal permeability, and were associated with the enrichment of specific enzymes. Serum and bone tissue inflammatory cytokines detection showed that the expression of TNF-α and IL-17A in the FMT group were significantly increased.Conclusion: Overall, our findings suggested gut microbiota from postmenopausal osteoporosis patients accelerate bone mass loss in mice. Aberrant gut microbiota might 3 / 31 play a causal role in the process of bone mass loss mediated by inflammation after the destruction of the intestinal barrier.

Estropausal gut microbiota transplant improves ovarian function in adult mice

The influence of the gut microbiome on ovarian aging

Gut Microbiota Modulates Osteoclast Glutathione Synthesis and Mitochondrial Biogenesis in Mice Subjected to Ovariectomy

Transcriptomic signatures of mouse ovarian aging and estropausal transition at single cell resolution

Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging

The microbiota extends the reproductive lifespan by safeguarding the ovarian reserve

17β-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice

The Ovarian Transcriptome of Reproductively Aged Multiparous Mice: Candidate Genes for Ovarian Cancer Protection

Fecal microbiota transplantation mitigates vaginal atrophy in ovariectomized mice

Metagenomic analysis revealed the association between gut microbiota and different ovary responses to controlled ovarian stimulation

P-591 Follicular Fluid-Derived Exosomes Rejuvenate Ovarian Aging Through Mir-320A-3p-mediated FOXQ1 Inhibition

EXOSOMES FROM CYCLIC MICE MODULATE LIVER TRANSCRIPTOME IN ESTROUPAUSE MICE INDEPENDENT OF AGE

Ovarian tissue autotransplantation improves longevity in mice

Fecal microbiota transplantation from postmenopausal osteoporosis human donors accelerated bone mass loss in mice

Modulation of the Gut Microbiota Structure with Probiotics and Isoflavone Alleviates Metabolic Disorder in Ovariectomized Mice

Fecal microbiota transplantation ameliorates bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and metabolic function

Brown adipose tissue-derived exosomes delay fertility decline in aging mice

The stromal microenvironment and ovarian aging: mechanisms and therapeutic opportunities

Systemic low-dose anti-fibrotic treatment attenuates ovarian aging in the mouse

Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction

Follicular Fluid-Derived Exosomes Rejuvenate Ovarian Aging Through Mir-320A-3p-mediated FOXQ1 Inhibition.